NKB: Thoracolumbosacral Pedicle Screw System

Product code NKB, “Thoracolumbosacral Pedicle Screw System” in FDA's classification database, is a Class II device type under 21 CFR 888.3070 (thoracolumbosacral pedicle screw system), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 914 clearances under NKB, 703 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NKB
Regulation
21 CFR 888.3070
Class
II
Panel
Orthopedic
Clearances
914
Most recent
Oct 2, 2026
Median review, last 2 years
77 days
Third-party review
Not eligible
Implant
Yes

What it covers

Intended to provide immobilization and stabilization of spinal segments in thoracic, lumbar, and sacral spine as an adjunct to fusion.

FDA’s definition of product code NKB, from the Product Classification database.

FDA flags NKB devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K261217AnyPlus II Spinal Fixation SystemGS Medical Co., Ltd.Oct 2, 2026Special
K263062NOVIX Pedicle Screw SystemTdm Co., Ltd.Oct 1, 2026Special
K263172SAS MIS Pelvic Incidence RodsSpinal Alignment Solutions, Inc.Sep 30, 2026Special
K262712Duet™ Spinal Fixation SystemDuet Spine Holdings, LLCSep 30, 2026Traditional
K252139Kentrospine Viktr-MIS® Pedicle screw systemRivarp Medical Pvt., Ltd.Sep 27, 2026Traditional
K262067iFuse Granite Onyx™ Implant SystemSI-BONE, Inc.Sep 23, 2026Traditional
K262091FRAXION Spinal Fixation SystemOrtler Global Tibbi Gerecler Anonim SirketiSep 17, 2026Traditional
K262193RIVA® Posterior Fixation System with NanoACTIV Surface Technology; RIVA® Anchor Sacroiliac Fixation System with NanoACTIV Surface TechnologyXenix MedicalSep 14, 2026Traditional
K262828KHEIRON® Spinal Fixation System, including patient specific K-RODS.M.A.I.OSep 4, 2026Special
K260362QUATTRO Spinal system (Open Configuration); QUATTRO-GADGET Spinal system (MIS Configuration)MANTIZ Co., Ltd.Jul 24, 2026Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 914 with a free account)

Clearances by year

703 NKB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)3091
20252461
20243957
20234472
20223488
20213261
20204868
20193984
20185661
20176369
20165084
20155590
20144690
20133573
20126079
20114884

Who submits

255 applicants cleared a NKB device since 2011. 72% of the clearances went to applicants in United States, then South Korea (7%), France (6%) and Switzerland (6%). By type: Traditional 67%, Special 32% and Abbreviated 1%.

ApplicantClearances since 2011
Medtronic Sofamor Danek USA, Inc.40
Alphatec Spine, Inc.19
L&K BIOMED Co., Ltd.17
K2m, Inc.16
Life Spine, Inc.16
Globus Medical, Inc.14
SeaSpine Orthopedics Corporation14
Medos International SARL13

How FDA classifies it

(1) Class II (special controls), when intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). These pedicle screw spinal systems must comply with the following special controls:

(i) Compliance with material standards;

(ii) Compliance with mechanical testing standards;

(iii) Compliance with biocompatibility standards; and

(iv) Labeling that contains these two statements in addition to other appropriate labeling information:

“Warning: The safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the thoracic, lumbar, and sacral spine secondary to severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra, degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other conditions are unknown.”

“Precaution: The implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.”

(2) Class II (special controls), when a rigid pedicle screw system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion in the treatment of degenerative disc disease and spondylolisthesis other than either severe spondylolisthesis (grades 3 and 4) at L5-S1 or degenerative spondylolisthesis with objective evidence of neurologic impairment. These pedicle screw systems must comply with the following special controls:

(i) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use.

(ii) Non-clinical performance testing must demonstrate the mechanical function and durability of the implant.

(iii) Device components must be demonstrated to be biocompatible.

(iv) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments.

(v) Labeling must include the following:

(A) A clear description of the technological features of the device including identification of device materials and the principles of device operation;

(B) Intended use and indications for use, including levels of fixation;

(C) Identification of magnetic resonance (MR) compatibility status;

(D) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user; and

(E) Detailed instructions of each surgical step, including device removal.

(3) Class II (special controls), when a semi-rigid system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion for any indication. In addition to complying with the special controls in paragraphs (b)(2)(i) through (v) of this section, these pedicle screw systems must comply with the following special controls:

(i) Demonstration that clinical performance characteristics of the device support the intended use of the product, including assessment of fusion compared to a clinically acceptable fusion rate.

(ii) Semi-rigid systems marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with the special controls in paragraphs (b)(2)(i) through (v) and paragraph (b)(3)(i) of this section.

From 21 CFR 888.3070. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 888.3070 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NKB clearances declared.

Ask about NKB

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NKB

What is FDA product code NKB?

Product code NKB, “Thoracolumbosacral Pedicle Screw System” in FDA's classification database, is a Class II device type under 21 CFR 888.3070 (thoracolumbosacral pedicle screw system), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 914 clearances under NKB, 703 of them since 2011.

How many 510(k) clearances are there under NKB?

FDA’s 510(k) database listed 914 clearances under NKB as of Oct 29, 2026, 703 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a NKB 510(k)?

For the 61 NKB clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 77 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NKB clearances?

Since 2011: Medtronic Sofamor Danek USA, Inc. (40), Alphatec Spine, Inc. (19), L&K BIOMED Co., Ltd. (17), K2m, Inc. (16) and Life Spine, Inc. (16). 255 applicants have cleared a NKB device in that time.

Sources

  1. FDA product classification: NKB · Product Classification database
  2. 21 CFR 888.3070: Thoracolumbosacral pedicle screw system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NKB · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NKBGet an email when FDA clears, recalls or publishes guidance for NKB devices.

Know what FDA already cleared.